Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

Lingappa, JR; Baeten, JM; Wald, A; Hughes, JP; Thomas, KK; Mujugira, A; Mugo, N; Bukusi, EA; Cohen, CR; Katabira, E; +30 more... Ronald, A; Kiarie, J; Farquhar, C; Stewart, GJ; Makhema, J; Essex, M; Were, E; Fife, KH; de Bruyn, G; Gray, GE; McIntyre, JA; Manongi, R; Kapiga, S; Coetzee, D; Allen, S; Inambao, M; Kayitenkore, K; Karita, E; Kanweka, W; Delany, S; Rees, H; Vwalika, B; Magaret, AS; Wang, RS; Kidoguchi, L; Barnes, L; Ridzon, R; Corey, L; Celum, C; Partners Prevention, HSVHIVT; (2010) Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet, 375 (9717). pp. 824-833. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(09)62038-9

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(09)62038-9

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar